Transcription factor STAT3 as a prognostic marker and therapeutic target in cancer

J Clin Oncol. 2013 Dec 20;31(36):4560-1. doi: 10.1200/JCO.2013.52.8414. Epub 2013 Nov 12.

Author

David A Frank¹

Affiliation

¹ Dana-Farber Cancer Institute; Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

PMID: 24220556
DOI: 10.1200/JCO.2013.52.8414

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Lymphoma, Large B-Cell, Diffuse / drug therapy*
Lymphoma, Large B-Cell, Diffuse / mortality*
Male
STAT3 Transcription Factor / metabolism*
Signal Transduction / drug effects*

Substances

STAT3 Transcription Factor
STAT3 protein, human